| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000029617 |
| Receipt No. | R000033409 |
| Scientific Title | Longitudinal study of the knee extension force for elderly patients with diabetes mellitus |
| Date of disclosure of the study information | 2017/10/18 |
| Last modified on | 2020/08/25 (Ver. 14) |
| Basic information | ||
| Public title | Longitudinal study of the knee extension force for elderly patients with diabetes mellitus | |
| Acronym | Multicenter survey of the isometric lower-extremity strength in type 2 diabetes: phase 2 (MUSCLE-std 2) | |
| Scientific Title | Longitudinal study of the knee extension force for elderly patients with diabetes mellitus | |
| Scientific Title:Acronym | Multicenter survey of the isometric lower-extremity strength in type 2 diabetes: phase 2 (MUSCLE-std 2) | |
| Region |
|
|
| Condition | |||
| Condition | Type 2 diabetes mellitus | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The purpose of this study was to examine the age-related loss of muscle strength and the influence of diabetic polyneuropathy in older patients with type 2 diabetes. |
| Basic objectives2 | Others |
| Basic objectives -Others | Comprehensive management of high-risk patients with type 2 diabetes. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Knee extension force |
| Key secondary outcomes | 1. Characteristics: body weight, length of lower leg, height, age, and a non-dominant leg.
2. Diabetes treatment-related information: Duration of diabetes, fasting plasma glucose (or postprandial plasma glucose), HbA1c, LDL cholesterol, HDL cholesterol, total cholesterol, trygriceride, serum creatinine, fasting insulin, the administration of diet therapy and the details of such diet therapy, the use of drug therapy and the details of drug therapy. 3. Diabetic polyneuropathy by a simple diagnosis standard neuropathy test: achilles' tendon reflex, vibratory sense on medial malleolus, subjective symptoms. 4. Complications associated with diabetes, complications not related to diabetes. 5. Clarify and evaluate the patient's normal exercise patterns, drinking habit, and smoking habit. 6. Loco check 25, EQ-5D |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Inpatients and/or outpatients with type 2 diabetes, who give written informed consent to participate in the study. | |||
| Key exclusion criteria | 1. Patients who could not adapt to the exercise therapy.
2. Independent walking is impossible. 3. Significant limitations in their activities of daily of living. 4. Severe heart and/or respiratory diseases. 5. Severe liver dysfunction and/or renal failure (serum creatinine over 2.0 mg/dL). 6. Patients having acute and/or chronic orthopedic disease, and who were presently receiving medical treatment. 7. Patients having non-symmetry of bilateral lower-extremity muscular atrophy. 8. Patients having an impairment of the lower-extremities. 9. Patients having severe infectious disease. 10. Patients requiring surgical treatment. 11. Other conditions that resulted in the patients being considered to be ineligible by the researcher. |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kansai University of Welfare Sciences | ||||||
| Division name | Department of Rehabilitation Sciences, Faculty of Allied Health Sciences | ||||||
| Zip code | 582-0026 | ||||||
| Address | 3-11-1, Asahigaoka, Kashiwara city, Osaka 582-0026, JAPAN | ||||||
| TEL | 072-978-0088 | ||||||
| tnomura@tamateyama.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kansai University of Welfare Sciences | ||||||
| Division name | Department of Rehabilitation Sciences, Faculty of Allied Health Sciences | ||||||
| Zip code | 582-0026 | ||||||
| Address | 3-11-1, Asahigaoka, Kashiwara city, Osaka 582-0026, JAPAN | ||||||
| TEL | 072-978-0088 | ||||||
| Homepage URL | |||||||
| tnomura@tamateyama.ac.jp | |||||||
| Sponsor | |
| Institute | Kansai University of Welfare Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Society for the Promotion of Science |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kansai University of Welfare Sciences |
| Address | 3-11-1, Asahigaoka, Kashiwara city, Osaka 582-0026, JAPAN |
| Tel | 072-978-0088 |
| umin-kfk@tamateyama.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 公立豊岡病院日高医療センター(兵庫県)、公立陶生病院(愛知県)、製鉄八幡病院(福岡県)、市立伊丹病院(兵庫県)、金沢赤十字病院(石川県)、市立吹田市民病院(大阪府)、公立甲賀病院(滋賀県)、広島大学病院(広島県)、KKR高松病院(香川県)
|
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://onlinelibrary.wiley.com/doi/10.1111/jdi.13354 |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://onlinelibrary.wiley.com/doi/10.1111/jdi.13354 | ||||||
| Number of participants that the trial has enrolled | 105 | ||||||
| Results | Relative KEF in the DPN group was significantly lower at follow up than at baseline. DPN significantly affected changes in relative KEF. Mobility decreased by 41 and 65 percents in the non-DPN and DPN groups, respectively. Quality adjusted life years were significantly lower in the DPN group than in the non-DPN group. Relative KEF was a significant independent variable that explained quality adjusted life years. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | This cohort study, termed Multicenter Survey of the Isometric Lower Extremity Strength in Type 2 Diabetes: Phase 2 (MUSCLE std 2), used the baseline data of the MUSCLE std study, which was a cross sectional survey carried out among 30 hospitals from April 2010 to March 2015. |
||||||
| Participant flow | Follow up data were collected in collaboration with nine of these hospitals from October 2015 to March 2019. |
||||||
| Adverse events | Non. |
||||||
| Outcome measures | Knee extension force, Diabetes status and drug therapy, Habitual behavior, Locomotive syndrome and HRQoL |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Nomura T, Kawae T, Kataoka H, Ikeda Y. Loss of lower extremity muscle strength based on diabetic polyneuropathy in older patients with type 2 diabetes: Multicenter Survey of the Isometric Lower Extremity Strength in Type 2 Diabetes: Phase 2 study. J Diabetes Investig, First published: 10 July 2020 https://doi.org/10.1111/jdi.13354
KAKEN https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-15K01440/ Nomura T, Kawae T, Kataoka H, Ikeda Y: Assessment of lower extremity muscle mass, muscle strength, and exercise therapy in elderly patients with diabetes mellitus. Environ Health Prev Med 23(1):20, 2018. Nomura T, Kawae T, Kataoka H, Ikeda Y: Aging, physical activity, and diabetic complications related to loss of muscle strength in patients with type 2 diabetes. Phy Ther Res 21(2):33-38, 2018. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033409 |